AVX901
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AVX901, covering 2018-03-29 to 2018-03-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 [Phase 1]